In conclusion, we report here that whole-body PHD1 deficiency promotes hepatic steatosis and liver-specific insulin resistance but does not worsen the deleterious effects of HFD on metabolic homeostasis. The gene discussed is EGLN2; the disease is Hepatic steatosis.